On July 13, 2026, the clinical trial registry recorded a status update for the study titled 'The Molecular Basis of Inherited Reproductive Disorders,' registered as NCT05971836. This trial, which involves kisspeptin, is listed with a status of completed. No phase was specified in the available data.
Kisspeptin remains classified as unapproved for research use, and this update reflects only a change in the trial's registered status. The trial record does not include results or outcome data in this update.
As this is a status update rather than a results posting, no findings, efficacy data, or safety conclusions can be drawn from this information. The completion of a trial phase indicates that the study has finished its planned activities, but does not by itself confirm what, if anything, was discovered.
Further details about the trial's design, objectives, and eventual results, if published, would be found in future updates to the same registry entry. Readers interested in kisspeptin's broader research context can consult the compound overview for additional background.